The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...
Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback